{"gene":"PF3D7_1036400","run_date":"2026-09-08T12:51:28","timeline":{"discoveries":[{"year":1987,"finding":"LSA1 (PF3D7_1036400) was identified as a P. falciparum liver-stage-specific antigen by gene cloning; the encoded protein contains tandem repeats of 17 amino acids and is immunogenic in humans.","method":"Gene cloning, DNA sequencing, immunological screening of expression library","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — original gene cloning with sequence characterization and immunological validation, foundational study replicated by subsequent work","pmids":["3306406"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1991,"finding":"LSA1 (PF3D7_1036400) encodes a ~200 kDa protein; structural analysis revealed N-terminal and C-terminal non-repetitive regions flanking a central repeat region composed of 17-amino-acid repeats.","method":"Molecular analysis / gene sequencing and structural characterization","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — structural characterization from sequencing with protein size determination, single study","pmids":["1840628"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1992,"finding":"HLA-B53-restricted cytotoxic T lymphocytes (CTLs) from malaria-immune Africans recognized a conserved nonamer peptide from LSA1 (PF3D7_1036400), identifying an HLA-B53-restricted CTL epitope in this antigen and providing a molecular basis for the HLA-B53/severe malaria resistance association.","method":"Peptide elution from HLA-B53, biochemical binding assays, cellular CTL assays with PBMCs from malaria-immune donors","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (peptide elution, biochemical assay, cellular assay), widely replicated in subsequent literature","pmids":["1280333"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1994,"finding":"LSA1 (PF3D7_1036400) protein is detected throughout liver schizogony and accumulates in the parasitophorous vacuole space; both the repetitive region and the C-terminal non-repetitive 'hinge' region contain major B- and T-cell determinants; the N- and C-terminal regions are highly conserved between strains T9/96 and NF54.","method":"Protein localization (immunofluorescence/immunostaining of infected hepatocytes), sequence analysis, peptide-based B- and T-cell immunological assays (antibody ELISA, IFN-γ secretion, T-cell proliferation)","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein localization in infected hepatocytes combined with multiple orthogonal immunological assays, single rigorous study with multiple methods","pmids":["7515922"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"NF54"},{"species":"Plasmodium falciparum","strain":"T9/96"}]},{"year":2003,"finding":"Synthetic peptides from the LSA1 (PF3D7_1036400) sequence (peptides 20630, 20637, 20638, 20639) bind specifically and saturably to HepG2 hepatocyte cell membranes; peptide 20630 bound to a 48 kDa HepG2 surface membrane protein. Peptides 20630 and 20633 also showed specific erythrocyte binding activity and inhibited merozoite invasion of erythrocytes in vitro; a monkey antiserum raised against a 20630 analog inhibited merozoite invasion in vitro.","method":"HepG2 cell binding assay, erythrocyte binding assay, in vitro merozoite invasion inhibition assay, SDS-PAGE identification of receptor protein","journal":"Peptides","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct binding and functional inhibition assays, but single lab, single study; invasion-inhibitory role of LSA1 peptides is mechanistically suggestive but not confirmed by reverse genetics","pmids":["12895649"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"finding":"Deletion of the lsa-1 locus in P. falciparum NF54 strain showed that LSA1 (PF3D7_1036400) is required for late liver-stage differentiation: lsa-1(-) sporozoites had normal gliding motility and hepatocyte invasion, but exhibited ~50% reduction in late liver-stage forms in a hepatocytic cell line at day 6, and a severe defect in late liver-stage schizogony and exo-erythrocytic merozoite formation in SCID/Alb-uPA mice with humanized livers at day 7. lsa-1(-) parasites also showed aberrant liver-stage expression of AMA-1 and circumsporozoite protein.","method":"Targeted gene deletion (reverse genetics), in vitro hepatocyte infection assay, in vivo SCID/Alb-uPA humanized mouse liver model, immunofluorescence assay for protein expression","journal":"Cellular microbiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with specific phenotypic readout validated in two independent experimental systems (cell line and humanized mouse), multiple orthogonal readouts including protein expression analysis","pmids":["21569184"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"NF54"}]},{"year":2005,"finding":"LSA1 (PF3D7_1036400) is expressed solely in infected hepatocytes and is thought to have a role in liver schizogony and merozoite release; a recombinant construct (LSA-NRC) incorporating the N- and C-terminal regions plus two central 17-aa repeats, when expressed in E. coli and used to immunize rabbits and mice, elicited antibodies that recognized liver-stage parasites in infected human hepatocytes in culture, and induced IFN-γ-producing splenocytes in mice.","method":"Recombinant protein expression in E. coli with codon harmonization, immunization of rabbits and mice, immunofluorescence assay on infected hepatocyte cultures, ELISpot for IFN-γ","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — recombinant antigen correctly recognized liver-stage parasites confirming localization, immune functional data in animal models; hepatocyte-specific expression confirmed","pmids":["15784552"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2025,"finding":"In a comparative analysis of antibody responses to 228 P. falciparum proteins following PfSPZ-CVac (chloroquine) immunization, protection was associated with antibodies to the liver-stage antigen LSA1 (PF3D7_1036400) and LISP2, but not to PfCSP, identifying LSA1 antibodies as a correlate of vaccine-induced sterile protection.","method":"Proteome-wide antibody profiling of 228 Pf proteins in clinical trial samples, comparative analysis between protected and non-protected vaccinees","journal":"EMBO molecular medicine","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — association from clinical trial immunological analysis, single study; correlative rather than mechanistic but links LSA1 antibodies to protection outcome","pmids":["41023197"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"LSA1 (PF3D7_1036400) is a ~200 kDa P. falciparum protein expressed exclusively during liver-stage (exo-erythrocytic) development, localizing to the parasitophorous vacuole space throughout liver schizogony; genetic deletion demonstrates it is dispensable for sporozoite gliding motility and hepatocyte invasion but is essential for late liver-stage schizogony and exo-erythrocytic merozoite formation, with its loss also causing aberrant expression of AMA-1 and CSP; the protein contains a central repeat domain of 17-amino-acid repeats flanked by conserved N- and C-terminal regions that harbor B-cell, CD4+ T-cell, and HLA-B53-restricted CD8+ T-cell (CTL) epitopes, and synthetic peptides from the sequence can bind hepatocyte membrane proteins and inhibit merozoite invasion of erythrocytes in vitro."},"narrative":{"mechanistic_narrative":"LSA1 (PF3D7_1036400) is a P. falciparum liver-stage-specific antigen expressed exclusively in infected hepatocytes during exo-erythrocytic development, where it functions in the maturation of the liver schizont [PMID:3306406, PMID:15784552]. The ~200 kDa protein has a modular architecture: a central domain of tandem 17-amino-acid repeats flanked by conserved N- and C-terminal non-repetitive regions [PMID:1840628], and throughout liver schizogony the protein accumulates in the parasitophorous vacuole space [PMID:7515922]. Its role is developmental rather than at parasite entry: targeted deletion of the locus in the NF54 strain leaves sporozoite gliding motility and hepatocyte invasion intact but causes a severe defect in late liver-stage schizogony and exo-erythrocytic merozoite formation, together with aberrant liver-stage expression of AMA-1 and circumsporozoite protein [PMID:21569184]. The conserved N- and C-terminal regions and the repeat domain carry major B-cell and T-cell determinants, including an HLA-B53-restricted CD8+ CTL epitope recognized by malaria-immune donors, providing a molecular basis for the HLA-B53/severe malaria resistance association [PMID:1280333, PMID:7515922], and antibodies to LSA1 are a correlate of PfSPZ-CVac-induced sterile protection [PMID:41023197]. Beyond these findings, the biochemical mechanism by which LSA1 controls liver-stage differentiation and the identity of its interacting partners have not been characterized in the available corpus.","teleology":[{"year":1987,"claim":"Established the existence of a dedicated liver-stage antigen in P. falciparum, opening the exo-erythrocytic stage to molecular and immunological study.","evidence":"Gene cloning, DNA sequencing and immunological screening of an expression library","pmids":["3306406"],"confidence":"High","gaps":["Protein size and full domain organization not yet resolved","No functional role assigned","Subcellular localization unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1991,"claim":"Defined the modular architecture of the ~200 kDa product, distinguishing a repetitive central core from conserved flanking regions that would later prove functionally and immunologically important.","evidence":"Gene sequencing and structural characterization of the protein","pmids":["1840628"],"confidence":"Medium","gaps":["Function of individual domains not tested","No structural model of the folded protein","Repeat number variability across strains not addressed"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1992,"claim":"Linked LSA1 to protective cellular immunity by identifying a conserved HLA-B53-restricted CTL epitope, giving a molecular rationale for the HLA-B53/severe malaria resistance association.","evidence":"Peptide elution from HLA-B53, biochemical binding assays and cellular CTL assays with PBMCs from malaria-immune Africans","pmids":["1280333"],"confidence":"High","gaps":["Whether CTL recognition contributes to sterile protection in vivo not established","Breadth of restricting HLA alleles not defined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1994,"claim":"Localized the protein to the parasitophorous vacuole space throughout liver schizogony and mapped B- and T-cell determinants to both the repeat and conserved C-terminal 'hinge' regions, tying immunogenicity to defined subregions.","evidence":"Immunofluorescence of infected hepatocytes, sequence conservation analysis across T9/96 and NF54, and peptide-based antibody, IFN-γ and proliferation assays","pmids":["7515922"],"confidence":"High","gaps":["Mechanistic role of vacuolar localization unresolved","No interacting vacuolar partners identified"],"attribution":[{"species":"Plasmodium falciparum","strain":"NF54"},{"species":"Plasmodium falciparum","strain":"T9/96"}]},{"year":2003,"claim":"Tested whether LSA1-derived peptides engage host cells, showing specific saturable binding to hepatocyte and erythrocyte membranes and in vitro inhibition of merozoite invasion.","evidence":"HepG2 and erythrocyte binding assays, SDS-PAGE identification of a 48 kDa HepG2 receptor, and in vitro merozoite invasion-inhibition assays with peptide-derived antisera","pmids":["12895649"],"confidence":"Medium","gaps":["Peptide binding not confirmed for the native protein by reverse genetics","Identity of the 48 kDa receptor not established","Single lab, single study"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"claim":"Confirmed hepatocyte-restricted expression and demonstrated that a recombinant N/C-terminal construct with central repeats is immunogenic and recognizes native liver-stage parasites, validating the antigen as a vaccine candidate scaffold.","evidence":"E. coli expression of codon-harmonized LSA-NRC, rabbit/mouse immunization, immunofluorescence on infected hepatocyte cultures and IFN-γ ELISpot","pmids":["15784552"],"confidence":"Medium","gaps":["Protective efficacy of the construct not demonstrated","Mechanistic role in schizogony inferred, not tested here"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"claim":"Resolved the functional role by genetic deletion, showing LSA1 is dispensable for sporozoite motility and hepatocyte invasion but essential for late liver-stage schizogony and merozoite formation, and required for proper AMA-1 and CSP expression.","evidence":"Targeted gene deletion in NF54, in vitro hepatocyte infection, in vivo SCID/Alb-uPA humanized-liver mouse model, and immunofluorescence for stage-specific protein expression","pmids":["21569184"],"confidence":"High","gaps":["Molecular pathway connecting LSA1 loss to arrested schizogony unknown","Mechanism by which LSA1 influences AMA-1 and CSP expression unresolved","No interacting partners identified"],"attribution":[{"species":"Plasmodium falciparum","strain":"NF54"}]},{"year":2025,"claim":"Connected LSA1 immunity to vaccine outcome, showing antibodies to LSA1 (with LISP2, but not PfCSP) correlate with PfSPZ-CVac-induced sterile protection.","evidence":"Proteome-wide antibody profiling of 228 Pf proteins in clinical trial samples comparing protected versus non-protected vaccinees","pmids":["41023197"],"confidence":"Medium","gaps":["Correlation does not establish that LSA1 antibodies are causally protective","Effector mechanism of LSA1 antibodies undefined","Single trial"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"The biochemical mechanism by which vacuolar LSA1 drives late liver-stage schizogony and coordinates AMA-1/CSP expression, and its molecular interaction partners, remain unknown.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No molecular partners or substrates identified","No structural model","Mechanism linking LSA1 to schizont maturation unresolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":[],"other_free_text":["Liver-stage (exo-erythrocytic) specific expression in infected hepatocytes [#0, #6]","~200 kDa protein with central 17-amino-acid tandem repeats flanked by conserved N- and C-terminal regions [#1]","Essential for late liver-stage schizogony and exo-erythrocytic merozoite formation; dispensable for sporozoite gliding and hepatocyte invasion [#5]","Loss causes aberrant liver-stage expression of AMA-1 and circumsporozoite protein [#5]","Carries HLA-B53-restricted CD8+ CTL, B-cell and CD4+ T-cell epitopes [#2, #3]","Peptides bind a 48 kDa HepG2 surface protein and inhibit merozoite invasion of erythrocytes in vitro [#4]","Antibodies to LSA1 correlate with PfSPZ-CVac-induced sterile protection [#7]"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"1280333","id":"PMC_1280333","title":"Molecular analysis of the association of HLA-B53 and resistance to severe malaria.","date":"1992","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1280333","citation_count":579,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9584096","id":"PMC_9584096","title":"Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum.","date":"1998","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9584096","citation_count":213,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"7630387","id":"PMC_7630387","title":"Natural selection on Plasmodium surface proteins.","date":"1995","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/7630387","citation_count":163,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"3306406","id":"PMC_3306406","title":"A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3306406","citation_count":155,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15755604","id":"PMC_15755604","title":"Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.","date":"2005","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/15755604","citation_count":152,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"7536870","id":"PMC_7536870","title":"Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria.","date":"1995","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7536870","citation_count":130,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"7515922","id":"PMC_7515922","title":"Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7515922","citation_count":119,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"8751936","id":"PMC_8751936","title":"NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.","date":"1996","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/8751936","citation_count":110,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16014863","id":"PMC_16014863","title":"Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.","date":"2005","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/16014863","citation_count":104,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20041125","id":"PMC_20041125","title":"Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20041125","citation_count":91,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21628654","id":"PMC_21628654","title":"Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic.","date":"2011","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21628654","citation_count":86,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18275273","id":"PMC_18275273","title":"Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.","date":"2008","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18275273","citation_count":77,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24351974","id":"PMC_24351974","title":"Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis.","date":"2013","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/24351974","citation_count":73,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"1840628","id":"PMC_1840628","title":"Structure of Plasmodium falciparum liver stage antigen-1.","date":"1991","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/1840628","citation_count":72,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"10377122","id":"PMC_10377122","title":"Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum.","date":"1999","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10377122","citation_count":70,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19737527","id":"PMC_19737527","title":"Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.","date":"2009","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/19737527","citation_count":70,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17035513","id":"PMC_17035513","title":"Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens.","date":"2006","source":"Clinical and vaccine immunology : CVI","url":"https://pubmed.ncbi.nlm.nih.gov/17035513","citation_count":67,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17330398","id":"PMC_17330398","title":"Malaria vaccines: are we getting closer?","date":"2007","source":"Current opinion in molecular therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/17330398","citation_count":63,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15784552","id":"PMC_15784552","title":"Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum.","date":"2005","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15784552","citation_count":59,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9712767","id":"PMC_9712767","title":"Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.","date":"1998","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9712767","citation_count":59,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9393799","id":"PMC_9393799","title":"T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic.","date":"1997","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9393799","citation_count":58,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11323304","id":"PMC_11323304","title":"Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine.","date":"2001","source":"Trends in parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11323304","citation_count":55,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20823210","id":"PMC_20823210","title":"Multiple antigen peptide vaccines against Plasmodium falciparum malaria.","date":"2010","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20823210","citation_count":52,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11535306","id":"PMC_11535306","title":"A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.","date":"2001","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/11535306","citation_count":52,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17041140","id":"PMC_17041140","title":"Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.","date":"2006","source":"Clinical microbiology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17041140","citation_count":49,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"14694197","id":"PMC_14694197","title":"A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14694197","citation_count":49,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21059211","id":"PMC_21059211","title":"A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.","date":"2010","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/21059211","citation_count":49,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26139288","id":"PMC_26139288","title":"Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26139288","citation_count":49,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24970846","id":"PMC_24970846","title":"Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.","date":"2014","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24970846","citation_count":47,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15322007","id":"PMC_15322007","title":"Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.","date":"2004","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15322007","citation_count":46,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18505558","id":"PMC_18505558","title":"Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru.","date":"2008","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/18505558","citation_count":46,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12874308","id":"PMC_12874308","title":"Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya.","date":"2003","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12874308","citation_count":44,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20667138","id":"PMC_20667138","title":"Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study.","date":"2010","source":"Infectious agents and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20667138","citation_count":44,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"10603392","id":"PMC_10603392","title":"Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.","date":"2000","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10603392","citation_count":44,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15271893","id":"PMC_15271893","title":"Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.","date":"2004","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15271893","citation_count":43,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21569184","id":"PMC_21569184","title":"Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.","date":"2011","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21569184","citation_count":42,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21689436","id":"PMC_21689436","title":"Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.","date":"2011","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/21689436","citation_count":39,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9889408","id":"PMC_9889408","title":"Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria.","date":"1998","source":"European cytokine network","url":"https://pubmed.ncbi.nlm.nih.gov/9889408","citation_count":38,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23897618","id":"PMC_23897618","title":"Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA.","date":"2013","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23897618","citation_count":37,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29444078","id":"PMC_29444078","title":"Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique.","date":"2018","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29444078","citation_count":37,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"10948144","id":"PMC_10948144","title":"Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya.","date":"2000","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10948144","citation_count":36,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18809666","id":"PMC_18809666","title":"Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.","date":"2008","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18809666","citation_count":36,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17954725","id":"PMC_17954725","title":"Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.","date":"2007","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/17954725","citation_count":34,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19686691","id":"PMC_19686691","title":"Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.","date":"2009","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/19686691","citation_count":34,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11012976","id":"PMC_11012976","title":"HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT.","date":"2000","source":"Parasite immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11012976","citation_count":34,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30949162","id":"PMC_30949162","title":"Comprehensive Review of Human Plasmodium falciparum-Specific CD8+ T Cell Epitopes.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30949162","citation_count":33,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11076705","id":"PMC_11076705","title":"HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections.","date":"2000","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/11076705","citation_count":33,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23151451","id":"PMC_23151451","title":"Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.","date":"2012","source":"Human vaccines & immunotherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23151451","citation_count":33,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"10506649","id":"PMC_10506649","title":"Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids.","date":"1999","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/10506649","citation_count":32,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17925026","id":"PMC_17925026","title":"Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.","date":"2007","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/17925026","citation_count":32,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9854139","id":"PMC_9854139","title":"In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.","date":"1998","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9854139","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1","PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15318164","id":"PMC_15318164","title":"Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.","date":"2004","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15318164","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16760507","id":"PMC_16760507","title":"Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers.","date":"2006","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/16760507","citation_count":29,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12135271","id":"PMC_12135271","title":"Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.","date":"2002","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/12135271","citation_count":28,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9632616","id":"PMC_9632616","title":"Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.","date":"1998","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9632616","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25446174","id":"PMC_25446174","title":"Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.","date":"2014","source":"Acta tropica","url":"https://pubmed.ncbi.nlm.nih.gov/25446174","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11132389","id":"PMC_11132389","title":"Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria.","date":"2000","source":"Transactions of the Royal Society of Tropical Medicine and Hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/11132389","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12749493","id":"PMC_12749493","title":"Effects of permethrin-treated bed nets on immunity to malaria in western Kenya II. Antibody responses in young children in an area of intense malaria transmission.","date":"2003","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/12749493","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"14977967","id":"PMC_14977967","title":"Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.","date":"2004","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/14977967","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11447164","id":"PMC_11447164","title":"Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.","date":"2001","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11447164","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"10603380","id":"PMC_10603380","title":"Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.","date":"2000","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10603380","citation_count":26,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1","PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22059951","id":"PMC_22059951","title":"Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays.","date":"2011","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/22059951","citation_count":25,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16094220","id":"PMC_16094220","title":"Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya.","date":"2005","source":"The Pediatric infectious disease journal","url":"https://pubmed.ncbi.nlm.nih.gov/16094220","citation_count":25,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12164290","id":"PMC_12164290","title":"Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission.","date":"2002","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/12164290","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11012624","id":"PMC_11012624","title":"Influence of age and HLA type on interferon-gamma (IFN-gamma) responses to a naturally occurring polymorphic epitope of Plasmodium falciparum liver stage antigen-1 (LSA-1).","date":"2000","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11012624","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25405724","id":"PMC_25405724","title":"Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25405724","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"7477115","id":"PMC_7477115","title":"Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates.","date":"1995","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/7477115","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21956928","id":"PMC_21956928","title":"Humoral immune responses to Plasmodium falciparum among HIV-1-infected Kenyan adults.","date":"2011","source":"Proteomics. Clinical applications","url":"https://pubmed.ncbi.nlm.nih.gov/21956928","citation_count":20,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25604473","id":"PMC_25604473","title":"Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.","date":"2015","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/25604473","citation_count":20,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18212075","id":"PMC_18212075","title":"Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.","date":"2008","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18212075","citation_count":19,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16606988","id":"PMC_16606988","title":"Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area.","date":"2006","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/16606988","citation_count":19,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12749487","id":"PMC_12749487","title":"Effects of permethrin-treated bed nets on immunity to malaria in western Kenya I. Antibody responses in pregnant women and cord blood in an area of intense malaria transmission.","date":"2003","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/12749487","citation_count":19,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17101665","id":"PMC_17101665","title":"Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.","date":"2006","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/17101665","citation_count":18,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9683893","id":"PMC_9683893","title":"Biology of malarial liver stages: implications for vaccine design.","date":"1998","source":"Annals of tropical medicine and parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/9683893","citation_count":17,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19706920","id":"PMC_19706920","title":"Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya.","date":"2009","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/19706920","citation_count":17,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12895649","id":"PMC_12895649","title":"Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes.","date":"2003","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/12895649","citation_count":17,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"14613510","id":"PMC_14613510","title":"Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western Kenya.","date":"2003","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/14613510","citation_count":16,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33124533","id":"PMC_33124533","title":"Antibody Correlates of Protection from Clinical Plasmodium falciparum Malaria in an Area of Low and Unstable Malaria Transmission.","date":"2020","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/33124533","citation_count":15,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18928377","id":"PMC_18928377","title":"Effect of placental malaria and HIV infection on the antibody responses to Plasmodium falciparum in infants.","date":"2008","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18928377","citation_count":14,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"41023197","id":"PMC_41023197","title":"Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil.","date":"2025","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41023197","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"40791414","id":"PMC_40791414","title":"Computational Prioritization of T Cell Epitopes to Overcome HLA Restriction and Antigenic Diversity in Plasmodium falciparum.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40791414","citation_count":1,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"39730380","id":"PMC_39730380","title":"Principal component analysis of the Serological response to Plasmodium Falciparum using a Multiplex bead-based assay in Nigeria.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39730380","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38254075","id":"PMC_38254075","title":"Geospatial analysis of Plasmodium falciparum serological indicators: school versus community sampling in a low-transmission malaria setting.","date":"2024","source":"BMC medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38254075","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36403045","id":"PMC_36403045","title":"Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area.","date":"2022","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/36403045","citation_count":6,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"35697275","id":"PMC_35697275","title":"Cyclic constrained immunoreactive peptides from crucial P. falciparum proteins: potential implications in malaria diagnostics.","date":"2022","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35697275","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36425785","id":"PMC_36425785","title":"Spatial, environmental, and individual associations with Anopheles albimanus salivary antigen IgG in Haitian children.","date":"2022","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36425785","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31931834","id":"PMC_31931834","title":"Analysis of anti-Plasmodium IgG profiles among Fulani nomadic pastoralists in northern Senegal to assess malaria exposure.","date":"2020","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/31931834","citation_count":12,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33124539","id":"PMC_33124539","title":"Antibody Profiles to P. falciparum Antigens Over Time Characterize Acute and Long-Term Malaria Exposure in an Area of Low and Unstable Transmission.","date":"2020","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/33124539","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31740525","id":"PMC_31740525","title":"Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.","date":"2020","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31740525","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33032606","id":"PMC_33032606","title":"Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname.","date":"2020","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/33032606","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32192514","id":"PMC_32192514","title":"Practical example of multiple antibody screening for evaluation of malaria control strategies.","date":"2020","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/32192514","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32228699","id":"PMC_32228699","title":"Screening for malaria antigen and anti-malarial IgG antibody in forcibly-displaced Myanmar nationals: Cox's Bazar district, Bangladesh, 2018.","date":"2020","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/32228699","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30828645","id":"PMC_30828645","title":"Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso.","date":"2019","source":"Wellcome open research","url":"https://pubmed.ncbi.nlm.nih.gov/30828645","citation_count":10,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31455373","id":"PMC_31455373","title":"Sero-identification of the aetiologies of human malaria exposure (Plasmodium spp.) in the Limu Kossa District of Jimma Zone, South western Ethiopia.","date":"2019","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/31455373","citation_count":10,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28245264","id":"PMC_28245264","title":"Longitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28245264","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28097063","id":"PMC_28097063","title":"Interferon-γ responses to Plasmodium falciparum vaccine candidate antigens decrease in the absence of malaria transmission.","date":"2017","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/28097063","citation_count":6,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28962616","id":"PMC_28962616","title":"Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens.","date":"2017","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/28962616","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29016339","id":"PMC_29016339","title":"Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.","date":"2017","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/29016339","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["LSA1","liver stage antigen 1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26659715","id":"PMC_26659715","title":"Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26659715","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfLSA1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56422,"output_tokens":2516,"usd":0.103503,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7977,"output_tokens":3487,"usd":0.06353,"stage2_stop_reason":"end_turn"},"total_usd":0.167033,"stage1_batch_id":"msgbatch_01DisAaTypwmC8QwdMBuePHo","stage2_batch_id":"msgbatch_0184zxZTqxiEfdYYfPMfkqjb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"LSA1 (PF3D7_1036400) was identified as a P. falciparum liver-stage-specific antigen by gene cloning; the encoded protein contains tandem repeats of 17 amino acids and is immunogenic in humans.\",\n      \"method\": \"Gene cloning, DNA sequencing, immunological screening of expression library\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — original gene cloning with sequence characterization and immunological validation, foundational study replicated by subsequent work\",\n      \"pmids\": [\"3306406\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"LSA1 (PF3D7_1036400) encodes a ~200 kDa protein; structural analysis revealed N-terminal and C-terminal non-repetitive regions flanking a central repeat region composed of 17-amino-acid repeats.\",\n      \"method\": \"Molecular analysis / gene sequencing and structural characterization\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — structural characterization from sequencing with protein size determination, single study\",\n      \"pmids\": [\"1840628\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"HLA-B53-restricted cytotoxic T lymphocytes (CTLs) from malaria-immune Africans recognized a conserved nonamer peptide from LSA1 (PF3D7_1036400), identifying an HLA-B53-restricted CTL epitope in this antigen and providing a molecular basis for the HLA-B53/severe malaria resistance association.\",\n      \"method\": \"Peptide elution from HLA-B53, biochemical binding assays, cellular CTL assays with PBMCs from malaria-immune donors\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (peptide elution, biochemical assay, cellular assay), widely replicated in subsequent literature\",\n      \"pmids\": [\"1280333\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"LSA1 (PF3D7_1036400) protein is detected throughout liver schizogony and accumulates in the parasitophorous vacuole space; both the repetitive region and the C-terminal non-repetitive 'hinge' region contain major B- and T-cell determinants; the N- and C-terminal regions are highly conserved between strains T9/96 and NF54.\",\n      \"method\": \"Protein localization (immunofluorescence/immunostaining of infected hepatocytes), sequence analysis, peptide-based B- and T-cell immunological assays (antibody ELISA, IFN-γ secretion, T-cell proliferation)\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein localization in infected hepatocytes combined with multiple orthogonal immunological assays, single rigorous study with multiple methods\",\n      \"pmids\": [\"7515922\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"NF54\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"T9/96\"}]\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Synthetic peptides from the LSA1 (PF3D7_1036400) sequence (peptides 20630, 20637, 20638, 20639) bind specifically and saturably to HepG2 hepatocyte cell membranes; peptide 20630 bound to a 48 kDa HepG2 surface membrane protein. Peptides 20630 and 20633 also showed specific erythrocyte binding activity and inhibited merozoite invasion of erythrocytes in vitro; a monkey antiserum raised against a 20630 analog inhibited merozoite invasion in vitro.\",\n      \"method\": \"HepG2 cell binding assay, erythrocyte binding assay, in vitro merozoite invasion inhibition assay, SDS-PAGE identification of receptor protein\",\n      \"journal\": \"Peptides\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct binding and functional inhibition assays, but single lab, single study; invasion-inhibitory role of LSA1 peptides is mechanistically suggestive but not confirmed by reverse genetics\",\n      \"pmids\": [\"12895649\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Deletion of the lsa-1 locus in P. falciparum NF54 strain showed that LSA1 (PF3D7_1036400) is required for late liver-stage differentiation: lsa-1(-) sporozoites had normal gliding motility and hepatocyte invasion, but exhibited ~50% reduction in late liver-stage forms in a hepatocytic cell line at day 6, and a severe defect in late liver-stage schizogony and exo-erythrocytic merozoite formation in SCID/Alb-uPA mice with humanized livers at day 7. lsa-1(-) parasites also showed aberrant liver-stage expression of AMA-1 and circumsporozoite protein.\",\n      \"method\": \"Targeted gene deletion (reverse genetics), in vitro hepatocyte infection assay, in vivo SCID/Alb-uPA humanized mouse liver model, immunofluorescence assay for protein expression\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with specific phenotypic readout validated in two independent experimental systems (cell line and humanized mouse), multiple orthogonal readouts including protein expression analysis\",\n      \"pmids\": [\"21569184\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"NF54\"}]\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LSA1 (PF3D7_1036400) is expressed solely in infected hepatocytes and is thought to have a role in liver schizogony and merozoite release; a recombinant construct (LSA-NRC) incorporating the N- and C-terminal regions plus two central 17-aa repeats, when expressed in E. coli and used to immunize rabbits and mice, elicited antibodies that recognized liver-stage parasites in infected human hepatocytes in culture, and induced IFN-γ-producing splenocytes in mice.\",\n      \"method\": \"Recombinant protein expression in E. coli with codon harmonization, immunization of rabbits and mice, immunofluorescence assay on infected hepatocyte cultures, ELISpot for IFN-γ\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — recombinant antigen correctly recognized liver-stage parasites confirming localization, immune functional data in animal models; hepatocyte-specific expression confirmed\",\n      \"pmids\": [\"15784552\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In a comparative analysis of antibody responses to 228 P. falciparum proteins following PfSPZ-CVac (chloroquine) immunization, protection was associated with antibodies to the liver-stage antigen LSA1 (PF3D7_1036400) and LISP2, but not to PfCSP, identifying LSA1 antibodies as a correlate of vaccine-induced sterile protection.\",\n      \"method\": \"Proteome-wide antibody profiling of 228 Pf proteins in clinical trial samples, comparative analysis between protected and non-protected vaccinees\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — association from clinical trial immunological analysis, single study; correlative rather than mechanistic but links LSA1 antibodies to protection outcome\",\n      \"pmids\": [\"41023197\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"LSA1 (PF3D7_1036400) is a ~200 kDa P. falciparum protein expressed exclusively during liver-stage (exo-erythrocytic) development, localizing to the parasitophorous vacuole space throughout liver schizogony; genetic deletion demonstrates it is dispensable for sporozoite gliding motility and hepatocyte invasion but is essential for late liver-stage schizogony and exo-erythrocytic merozoite formation, with its loss also causing aberrant expression of AMA-1 and CSP; the protein contains a central repeat domain of 17-amino-acid repeats flanked by conserved N- and C-terminal regions that harbor B-cell, CD4+ T-cell, and HLA-B53-restricted CD8+ T-cell (CTL) epitopes, and synthetic peptides from the sequence can bind hepatocyte membrane proteins and inhibit merozoite invasion of erythrocytes in vitro.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"LSA1 (PF3D7_1036400) is a P. falciparum liver-stage-specific antigen expressed exclusively in infected hepatocytes during exo-erythrocytic development, where it functions in the maturation of the liver schizont [#0, #6]. The ~200 kDa protein has a modular architecture: a central domain of tandem 17-amino-acid repeats flanked by conserved N- and C-terminal non-repetitive regions [#1], and throughout liver schizogony the protein accumulates in the parasitophorous vacuole space [#3]. Its role is developmental rather than at parasite entry: targeted deletion of the locus in the NF54 strain leaves sporozoite gliding motility and hepatocyte invasion intact but causes a severe defect in late liver-stage schizogony and exo-erythrocytic merozoite formation, together with aberrant liver-stage expression of AMA-1 and circumsporozoite protein [#5]. The conserved N- and C-terminal regions and the repeat domain carry major B-cell and T-cell determinants, including an HLA-B53-restricted CD8+ CTL epitope recognized by malaria-immune donors, providing a molecular basis for the HLA-B53/severe malaria resistance association [#2, #3], and antibodies to LSA1 are a correlate of PfSPZ-CVac-induced sterile protection [#7]. Beyond these findings, the biochemical mechanism by which LSA1 controls liver-stage differentiation and the identity of its interacting partners have not been characterized in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Established the existence of a dedicated liver-stage antigen in P. falciparum, opening the exo-erythrocytic stage to molecular and immunological study.\",\n      \"evidence\": \"Gene cloning, DNA sequencing and immunological screening of an expression library\",\n      \"pmids\": [\"3306406\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protein size and full domain organization not yet resolved\", \"No functional role assigned\", \"Subcellular localization unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Defined the modular architecture of the ~200 kDa product, distinguishing a repetitive central core from conserved flanking regions that would later prove functionally and immunologically important.\",\n      \"evidence\": \"Gene sequencing and structural characterization of the protein\",\n      \"pmids\": [\"1840628\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Function of individual domains not tested\", \"No structural model of the folded protein\", \"Repeat number variability across strains not addressed\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Linked LSA1 to protective cellular immunity by identifying a conserved HLA-B53-restricted CTL epitope, giving a molecular rationale for the HLA-B53/severe malaria resistance association.\",\n      \"evidence\": \"Peptide elution from HLA-B53, biochemical binding assays and cellular CTL assays with PBMCs from malaria-immune Africans\",\n      \"pmids\": [\"1280333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CTL recognition contributes to sterile protection in vivo not established\", \"Breadth of restricting HLA alleles not defined\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Localized the protein to the parasitophorous vacuole space throughout liver schizogony and mapped B- and T-cell determinants to both the repeat and conserved C-terminal 'hinge' regions, tying immunogenicity to defined subregions.\",\n      \"evidence\": \"Immunofluorescence of infected hepatocytes, sequence conservation analysis across T9/96 and NF54, and peptide-based antibody, IFN-\\u03b3 and proliferation assays\",\n      \"pmids\": [\"7515922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic role of vacuolar localization unresolved\", \"No interacting vacuolar partners identified\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"NF54\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"T9/96\"}]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Tested whether LSA1-derived peptides engage host cells, showing specific saturable binding to hepatocyte and erythrocyte membranes and in vitro inhibition of merozoite invasion.\",\n      \"evidence\": \"HepG2 and erythrocyte binding assays, SDS-PAGE identification of a 48 kDa HepG2 receptor, and in vitro merozoite invasion-inhibition assays with peptide-derived antisera\",\n      \"pmids\": [\"12895649\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Peptide binding not confirmed for the native protein by reverse genetics\", \"Identity of the 48 kDa receptor not established\", \"Single lab, single study\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Confirmed hepatocyte-restricted expression and demonstrated that a recombinant N/C-terminal construct with central repeats is immunogenic and recognizes native liver-stage parasites, validating the antigen as a vaccine candidate scaffold.\",\n      \"evidence\": \"E. coli expression of codon-harmonized LSA-NRC, rabbit/mouse immunization, immunofluorescence on infected hepatocyte cultures and IFN-\\u03b3 ELISpot\",\n      \"pmids\": [\"15784552\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Protective efficacy of the construct not demonstrated\", \"Mechanistic role in schizogony inferred, not tested here\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved the functional role by genetic deletion, showing LSA1 is dispensable for sporozoite motility and hepatocyte invasion but essential for late liver-stage schizogony and merozoite formation, and required for proper AMA-1 and CSP expression.\",\n      \"evidence\": \"Targeted gene deletion in NF54, in vitro hepatocyte infection, in vivo SCID/Alb-uPA humanized-liver mouse model, and immunofluorescence for stage-specific protein expression\",\n      \"pmids\": [\"21569184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular pathway connecting LSA1 loss to arrested schizogony unknown\", \"Mechanism by which LSA1 influences AMA-1 and CSP expression unresolved\", \"No interacting partners identified\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"NF54\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected LSA1 immunity to vaccine outcome, showing antibodies to LSA1 (with LISP2, but not PfCSP) correlate with PfSPZ-CVac-induced sterile protection.\",\n      \"evidence\": \"Proteome-wide antibody profiling of 228 Pf proteins in clinical trial samples comparing protected versus non-protected vaccinees\",\n      \"pmids\": [\"41023197\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlation does not establish that LSA1 antibodies are causally protective\", \"Effector mechanism of LSA1 antibodies undefined\", \"Single trial\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The biochemical mechanism by which vacuolar LSA1 drives late liver-stage schizogony and coordinates AMA-1/CSP expression, and its molecular interaction partners, remain unknown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No molecular partners or substrates identified\", \"No structural model\", \"Mechanism linking LSA1 to schizont maturation unresolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042605\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0005102\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020003\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0070826\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": [\n      \"Liver-stage (exo-erythrocytic) specific expression in infected hepatocytes [#0, #6]\",\n      \"~200 kDa protein with central 17-amino-acid tandem repeats flanked by conserved N- and C-terminal regions [#1]\",\n      \"Essential for late liver-stage schizogony and exo-erythrocytic merozoite formation; dispensable for sporozoite gliding and hepatocyte invasion [#5]\",\n      \"Loss causes aberrant liver-stage expression of AMA-1 and circumsporozoite protein [#5]\",\n      \"Carries HLA-B53-restricted CD8+ CTL, B-cell and CD4+ T-cell epitopes [#2, #3]\",\n      \"Peptides bind a 48 kDa HepG2 surface protein and inhibit merozoite invasion of erythrocytes in vitro [#4]\",\n      \"Antibodies to LSA1 correlate with PfSPZ-CVac-induced sterile protection [#7]\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1036400","name":null,"product":"liver stage antigen 1","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"LSA1","evaluation":null}